ADPT insider trading
NasdaqGS HealthcareAdaptive Biotechnologies Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. It has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Company website: www.adaptivebiotech.com
ADPT insider activity at a glance
FilingIQ has scored 1,658 insider transactions for ADPT since Feb 18, 2015. The most recent filing in our index is dated Apr 27, 2026.
Across the full history, 7 open-market purchases
and 907 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ADPT insider trades is 61.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ADPT Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading ADPT
Frequently asked
- How many insider trades does FilingIQ track for ADPT?
- FilingIQ tracks 1,658 Form 4 insider transactions for ADPT (Adaptive Biotechnologies Corp), covering filings from Feb 18, 2015 onwards. 184 of those were filed in the last 90 days.
- Are ADPT insiders net buyers or net sellers?
- Across the full Form 4 history for ADPT, 7 transactions (0%) were open-market purchases and 907 (55%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ADPT insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is ADPT in?
- Adaptive Biotechnologies Corp (ADPT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $2.48B.
Methodology & sources
Every ADPT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.